 |
| |
|
Recipient of Philadelphia Business journal “40 under 40” award, Physician turned entrepreneur, Dr. Raza Bokhari, has over the past several years, developed outstanding expertise in aggregating and accelerating life sciences and healthcare services companies. He has a vast knowledge base of developing creative concepts, implementing programs and forming strategic alliances. An effective "change agent" with several years of experience and expertise in start-up and turn-around businesses, he has a special knack of adeptly turning around financially struggling companies. Raza has, over the years, come to realize the special role of private equity funds, venture capital money, and leveraged debt partners, in executing accelerated growth trends in healthcare services and cancer diagnostics and therapeutics.
|
Click here for complete bio |
|
 |
 |
FSD Pharma aims to initiate a Phase 2 coronavirus treatment trial by end 2020 as it files IND
Sept 10, 2020 FSD Pharma CEO, Dr. Raza Bokhari speaks about filing with the FDA an IND Application to initiate phase 2 clinical trial to treat hospitalized COVID-19 patients. Click here to watch the full video
FSD Pharma says $10M in new capital is 'gratifying' as the firm makes progress in coronavirus trial
August 10, 2020 FSD Pharma CEO, Dr. Raza Bokhari, on Proactive Investors spoke about completing US$10 million registered offering and provides progress update on submitting IND Application to the FDA to use FSD201 to treat COVID-19 patients. Click here to watch the full video
FSD Pharma – FDA Approval to Submit I.N.D. Application for Compound to Treat Covid-19 Patients
July 2, 2020 Dr Raza Bokhari, FSD Pharma CEO, talks about developing its ultra micro PEA Compound to treat COVID-19.... Click here to watch the video.
|
| View Archive |
|
 |
|
 |
|
